Post by Kevin Kissner

🚨 Deal Announcement: Digital Therapy Meets Pharmaceutical Power - Building a Gamechanger in Cognitive Impairment Care 🧠 I first worked with Jakob Futorjanski, Rojahn Ahmadi, Vincent Primey, and the NeuroNation - Mind & Brain Health Technology team back in 2020, when we welcomed IMPACT Partners as a shareholder. Since then, the team has continued to execute relentlessly - always patient-first, always grounded in clinical validity, and always driven by a clear vision: narrowing the gap in cognitive care globally. Fast forward to May 2026: NeuroNation has now helped more than 30 million people worldwide and became a trailblazer for an entire #healthtech and #mentalhealth ecosystem in Germany. With Schwabe Group, the company has found the ideal partner for its next chapter. The combination of Schwabe’s scientific depth, regulatory expertise, and decades of trust with NeuroNation’s agility, user-centricity, and technological excellence creates a powerful foundation to meaningfully scale cognitive care and raise awareness around MCI. It was incredibly special to work with the team on this transaction again. Huge congratulations to Jakob Futorjanski, Rojahn Ahmadi, and the entire NeuroNation team, as well as Nicolas Touboulic and Clément Schuurman from Impact Partners. And a big thank you to Dr. Rebekka Hye-Knudsen and Matthieu Emonet, LL.M. (Shanghai, Berlin) from Dentons for your invaluable support throughout the process. Last but not least thank you to Dr. Cornel Martin, Dr. Isabel Freund, Till-Manuel Saur, Robert Marx, Caspar Graf Stauffenberg and everybody on the Schwabe side for the always great collaboration. Simon Costa Christian Lessig Christopher Spies Vihaan Purohit Philipp Baus Jannis Pulm #PavaPartners #healthtech #Berlin